Mayu Watanabe
Jun Eguchi
Naoko Kurooka
Eriko Eto3
Jun Wada- 1Department of Diabetology and Endocrinology, National Hospital Organization (NHO) Okayama Medical Center, Okayama, Japan
- 2Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
- 3Department of Obstetrics and Gynecology, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
A Correction on
Maternal circulating GPIHBP1 levels and neonatal outcomes in patients with gestational diabetes mellitus: a pilot study
By Watanabe M, Eguchi J, Kurooka N, Eto E, Masuyama H and Wada J (2025). Front. Clin. Diabetes Healthc. 6:1682012. doi: 10.3389/fcdhc.2025.1682012
The order of authors in the author list of the published paper was erroneously given as:
“Mayu Watanabe1,2*, Jun Wada2, Naoko Kurooka2, Eriko Eto3, Hisashi Masuyama3, Jun Eguchi2”
The correct author list reads:
“Mayu Watanabe1,2*, Jun Eguchi2, Naoko Kurooka2, Eriko Eto3, Hisashi Masuyama3, Jun Wada2”
The Author Contributions statement has been corrected to read:
“MW: Data curation, Conceptualization, Investigation, Methodology, Writing – review & editing, Writing – original draft, Formal Analysis. JE: Supervision, Writing – review & editing, Writing – original draft. NK: Supervision, Data curation, Writing – review & editing. EE: Supervision, Data curation, Writing – review & editing. HM: Supervision, Data curation, Writing – review & editing. JW: Writing – original draft, Supervision, Writing – review & editing.”
The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1), gestational diabetes mellitus (GDM), perinatal outcomes, placenta, triglyceride (TG)
Citation: Watanabe M, Eguchi J, Kurooka N, Eto E, Masuyama H and Wada J (2025) Correction: Maternal circulating GPIHBP1 levels and neonatal outcomes in patients with gestational diabetes mellitus: a pilot study. Front. Clin. Diabetes Healthc. 6:1724699. doi: 10.3389/fcdhc.2025.1724699
Received: 14 October 2025; Accepted: 17 October 2025;
Published: 27 October 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Watanabe, Eguchi, Kurooka, Eto, Masuyama and Wada. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Mayu Watanabe, bWF5dXcyOTRAZ21haWwuY29t